FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991093313> ?p ?o ?g. }

• W1991093313 endingPage "3007" @default.
• W1991093313 startingPage "3001" @default.
• W1991093313 abstract "We had previously reported that tetramethyl-O-NGDA (M4N), a synthetic derivative of the naturally occurring nordihydroguaiaretic acid (NDGA), is able to inhibit HIV Tat transactivation by blocking host Sp1 protein at the Sp1 cognate binding site on the HIV LTR promoter. The present studies were undertaken to examine whether M4N is able to inhibit the replication of herpes simplex virus (HSV), another Sp1-regulated virus. The results showed that in Vero cells, M4N inhibits at micromolar levels (IC50 = 43.5 μM) the expression of the herpes immediate early gene (α-ICP4), which is essential for HSV replication. An electrophoretic mobility shift assay, examining Sp1 binding to the α-ICP4 promoter, showed a significant inhibition of the control bands: 88% inhibition of the fast moving band (FMB) and 45% of the slow moving band (SMB), at 100 μM of drug concentration. Comparative studies between M4N and acycloguanosine (acyclovir, ACV) in cultured Vero cells revealed an interesting pattern in the drug sensitivity (IC50) and cytotoxicity (TC50) parameters. For M4N, the IC50 varied between 11.7 and 4 μM in 10 passages of HSV-1 and 4 passages of HSV-2 with no indication for a requirement of higher drug concentration. In contrast, for acyclovir, the IC50 increased from 7 μM in the first passage to 444 μM in the tenth passage of HSV-1, and >88 μM for the fourth passage of HSV-2, indicating a rapid build-up of drug resistance against acyclovir. While the selective index (SI), defined as the ratio: TC50/IC50, remained relatively constant for M4N; it dropped 60-fold for acyclovir in the endpoints of viral passages. Drug sensitivity for M4N toward the acyclovir-sensitive strain (sm44) and the acyclovir-resistant strain (ACV-10) of HSV-1 was similar, indicating no cross-resistance between M4N and acyclovir in their anti-HSV effects. These results may have an important clinical relevance since HSV has been shown to be a factor for spreading of HIV." @default.
• W1991093313 created "2016-06-24" @default.
• W1991093313 creator A5003705725 @default.
• W1991093313 creator A5009138501 @default.
• W1991093313 creator A5016488541 @default.
• W1991093313 creator A5023391383 @default.
• W1991093313 creator A5037229854 @default.
• W1991093313 creator A5041552684 @default.
• W1991093313 creator A5067888242 @default.
• W1991093313 creator A5081127647 @default.
• W1991093313 creator A5089092780 @default.
• W1991093313 date "1998-07-01" @default.
• W1991093313 modified "2023-10-18" @default.
• W1991093313 title "Antiviral Activities of Methylated Nordihydroguaiaretic Acids. 2. Targeting Herpes Simplex Virus Replication by the Mutation Insensitive Transcription Inhibitor Tetra-<i>O</i>-methyl-NDGA" @default.
• W1991093313 cites W1576021204 @default.
• W1991093313 cites W1970106134 @default.
• W1991093313 cites W1978501067 @default.
• W1991093313 cites W1983438549 @default.
• W1991093313 cites W1988944348 @default.
• W1991093313 cites W1997844736 @default.
• W1991093313 cites W2016295109 @default.
• W1991093313 cites W2037653294 @default.
• W1991093313 cites W2054021971 @default.
• W1991093313 cites W2063825413 @default.
• W1991093313 cites W2088067087 @default.
• W1991093313 cites W2089824168 @default.
• W1991093313 cites W2109689528 @default.
• W1991093313 cites W2118732329 @default.
• W1991093313 cites W2140863009 @default.
• W1991093313 cites W2146481809 @default.
• W1991093313 cites W2167414261 @default.
• W1991093313 cites W46561793 @default.
• W1991093313 cites W58744354 @default.
• W1991093313 doi "https://doi.org/10.1021/jm980182w" @default.
• W1991093313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9685239" @default.
• W1991093313 hasPublicationYear "1998" @default.
• W1991093313 type Work @default.
• W1991093313 sameAs 1991093313 @default.
• W1991093313 citedByCount "64" @default.
• W1991093313 countsByYear W19910933132012 @default.
• W1991093313 countsByYear W19910933132013 @default.
• W1991093313 countsByYear W19910933132014 @default.
• W1991093313 countsByYear W19910933132015 @default.
• W1991093313 countsByYear W19910933132017 @default.
• W1991093313 countsByYear W19910933132020 @default.
• W1991093313 countsByYear W19910933132021 @default.
• W1991093313 countsByYear W19910933132022 @default.
• W1991093313 countsByYear W19910933132023 @default.
• W1991093313 crossrefType "journal-article" @default.
• W1991093313 hasAuthorship W1991093313A5003705725 @default.
• W1991093313 hasAuthorship W1991093313A5009138501 @default.
• W1991093313 hasAuthorship W1991093313A5016488541 @default.
• W1991093313 hasAuthorship W1991093313A5023391383 @default.
• W1991093313 hasAuthorship W1991093313A5037229854 @default.
• W1991093313 hasAuthorship W1991093313A5041552684 @default.
• W1991093313 hasAuthorship W1991093313A5067888242 @default.
• W1991093313 hasAuthorship W1991093313A5081127647 @default.
• W1991093313 hasAuthorship W1991093313A5089092780 @default.
• W1991093313 hasConcept C104317684 @default.
• W1991093313 hasConcept C1292079 @default.
• W1991093313 hasConcept C140704245 @default.
• W1991093313 hasConcept C150194340 @default.
• W1991093313 hasConcept C153911025 @default.
• W1991093313 hasConcept C159047783 @default.
• W1991093313 hasConcept C181199279 @default.
• W1991093313 hasConcept C185592680 @default.
• W1991093313 hasConcept C202751555 @default.
• W1991093313 hasConcept C2522874641 @default.
• W1991093313 hasConcept C2776889390 @default.
• W1991093313 hasConcept C2777752497 @default.
• W1991093313 hasConcept C2777824588 @default.
• W1991093313 hasConcept C2780857362 @default.
• W1991093313 hasConcept C2781196997 @default.
• W1991093313 hasConcept C55493867 @default.
• W1991093313 hasConcept C86803240 @default.
• W1991093313 hasConcept C89138240 @default.
• W1991093313 hasConceptScore W1991093313C104317684 @default.
• W1991093313 hasConceptScore W1991093313C1292079 @default.
• W1991093313 hasConceptScore W1991093313C140704245 @default.
• W1991093313 hasConceptScore W1991093313C150194340 @default.
• W1991093313 hasConceptScore W1991093313C153911025 @default.
• W1991093313 hasConceptScore W1991093313C159047783 @default.
• W1991093313 hasConceptScore W1991093313C181199279 @default.
• W1991093313 hasConceptScore W1991093313C185592680 @default.
• W1991093313 hasConceptScore W1991093313C202751555 @default.
• W1991093313 hasConceptScore W1991093313C2522874641 @default.
• W1991093313 hasConceptScore W1991093313C2776889390 @default.
• W1991093313 hasConceptScore W1991093313C2777752497 @default.
• W1991093313 hasConceptScore W1991093313C2777824588 @default.
• W1991093313 hasConceptScore W1991093313C2780857362 @default.
• W1991093313 hasConceptScore W1991093313C2781196997 @default.
• W1991093313 hasConceptScore W1991093313C55493867 @default.
• W1991093313 hasConceptScore W1991093313C86803240 @default.
• W1991093313 hasConceptScore W1991093313C89138240 @default.
• W1991093313 hasIssue "16" @default.
• W1991093313 hasLocation W19910933131 @default.
• W1991093313 hasLocation W19910933132 @default.
• W1991093313 hasOpenAccess W1991093313 @default.

• next